News tagged with astrazeneca

Study shows experimental drug cuts stroke risk

(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.

Aug 30, 2009
5 / 5 (1) 0

FDA weighs approval of psychiatric drugs for kids

(AP) -- Three blockbuster psychiatric drugs currently approved for adults also appear to work in adolescents, though federal health officials have concerns about exposing younger patients to the drugs' side effects.

Jun 05, 2009
3 / 5 (2) 3

EU steps up generic pharma anti-trust probe

Europe stepped up action against drug companies snarling up the entry of cheaper generic medicines onto markets, announcing Friday spot inspections confirmed by British No.2 AstraZeneca.

Dec 03, 2010
not rated yet 0

Merck 2Q profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Jul 29, 2014
not rated yet 0

A better way to target tumors

In the past 40 years, scientists have learned a great deal about how cells become cancerous. Some of that knowledge has translated to new treatments, but most of the time doctors are forced to rely on standard ch ...

Nov 15, 2010
5 / 5 (1) 0

Drugmaker Vivus settles with biggest shareholder

(AP)—Obesity drugmaker Vivus has agreed to a settlement with its biggest shareholder, which has been fighting for greater control of the company. A long-time drug executive backed by the shareholder will become CEO and ...

Jul 19, 2013
1 / 5 (1) 0

AstraZeneca e-mails show debate on Seroquel risks

(AP) -- Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm ...

May 20, 2009
not rated yet 0

Takeda renames heartburn drug to avoid errors

(AP) -- Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.

Mar 04, 2010
not rated yet 0